Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)
mediaposted on 2020-12-08, 14:26 authored by Yasushi Ishigaki, Alena Strizek, Toshihiko Aranishi, Nobuhiro Arai, Takeshi Imaoka, Zhihong Cai, Hiroshi Maegawa
Article full text
The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.